Intel stock extends gains after report of possible U.S. government stake
Director John B. Replogle of Crocs, Inc. (NASDAQ:CROX) recently purchased shares of the company’s common stock, according to a Form 4 filing with the Securities and Exchange Commission. The purchase comes as the stock trades near its 52-week low of $73.76, having declined 25.9% in the past week. On August 8, 2025, Replogle acquired a total of 3,261 shares in two separate transactions, with prices ranging from $76.302 to $76.734, amounting to a total investment of $250084.
The first purchase involved 336 shares of Crocs common stock. The weighted average price was $76.302. These shares were bought in multiple transactions at prices ranging from $75.550 to $76.426. In a subsequent transaction on the same day, Replogle bought 2,925 shares at a weighted average price of $76.734. The price for these shares ranged from $76.595 to $76.750.
Following these transactions, Replogle directly owns 15,417 shares of Crocs, Inc. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value model. Discover more insights and 15 additional ProTips for CROX in the comprehensive InvestingPro Research Report.
In other recent news, Crocs Inc. reported better-than-expected earnings for the second quarter of 2025, with adjusted diluted earnings per share of $4.23, surpassing the forecasted $4.02. The company’s revenue also exceeded expectations, reaching $1.15 billion compared to the anticipated $1.14 billion. Despite these positive results, Crocs issued guidance that fell significantly below consensus expectations, leading to a series of analyst actions. KeyBanc Capital Markets reduced its price target for Crocs to $95, citing outlook concerns, while maintaining an Overweight rating. Similarly, BofA Securities lowered its price target to $99 due to disappointing third-quarter guidance but maintained a Buy rating. Williams Trading downgraded Crocs from Buy to Hold, with a new price target of $80, following the company’s weak consumer outlook. Barclays also downgraded Crocs from Overweight to Equalweight, reducing its price target to $81 amid macroeconomic uncertainty and challenges with its HEYDUDE brand. These developments reflect investor concerns over Crocs’ future performance despite its recent earnings beat.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.